Tyvaso 64 MCG kit
Ended Awarded
- Contract number
- 36C24526N0227
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,352
Award facts
- Contract value 100% obligated
- $17,351.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order contract to United Therapeutics Corp for the supply of Tyvaso 64 mcg kits, with a ceiling value of $17,351.60. This firm-fixed-price delivery order, issued on January 9, 2026, with an ultimate completion date of January 16, 2026, represents a continuation of the company's ongoing pharmaceutical supply relationship with the VA. The contract will be performed at a facility in Bartlett, Tennessee. No set-aside designation was applied to this award. United Therapeutics, a biotechnology company specializing in treatments for rare and life-threatening medical conditions, serves as the prime contractor with no identified subcontractors on this delivery order.
This delivery order was issued under United Therapeutics' existing Blanket Purchase Agreement (BPA) with the VA National Acquisition Center under the Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The underlying BPA, valued at approximately $207.1 million and extending through April 2026, enables VISNs across the country to procure specialized pharmaceutical products from United Therapeutics' portfolio, including Tyvaso, which is primarily used to treat pulmonary arterial hypertension. As a self-certified small disadvantaged business and manufacturer of specialized pharmaceuticals, United Therapeutics has received numerous delivery orders through this IDV, typically ranging from $13,000 to $367,000, supporting the VA's critical mission of providing essential medical treatments to the veteran population.
Quick answers
Who was awarded contract 36C24526N0227?
36C24526N0227 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on January 9, 2026.
How much is contract 36C24526N0227 worth?
The government has obligated $17,352 on 36C24526N0227.
Is contract 36C24526N0227 an order under another contract?
Yes. 36C24526N0227 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0227 competed?
The extent of competition for 36C24526N0227 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award